|
|
|
|
|
Novo Nordisk 
|
|
Novo Nordisk was founded during 1923 having its headquarters situated at Bagsvaerd in Denmark for manufacturing and marketing the pharmaceutical products and related services. Ever since its establishment, the company is enjoying the foremost position in diabetes care with the widest range of anti-diabetic product category in the industry. This includes the most latest and excellent products within the insulin delivery system sector. Besides this, Novo Nordisk is ranked the zenith position in several other sectors like Haemostasis management, growth hormone therapy as well as hormone replacement therapy – HRT.
Besides, company’s apex status across the world in the diabetes care and strong belief of being the strongest follower of ‘triple bottom line’ Novo Nordisk has supported the International Diabetes Federation’s Unite for Diabetes campaign which has succeeded in obtaining the United Nation’s Resolution on Diabetes. Novo Nordisk is the healthcare company and is adored as the major company in diabetes care.
The company is committed to produce and sell the pharmaceutical products and services that are poised to make the vital difference to the patients, the medical profession and the society on the whole. The company employs nearly 23,600 people in around 79 nations and sells its products in almost 179 countries across the world today.
The major and reputed product range of Novo Nordisk includes several sectors like:
Diabetic Care: Levemir – the Basal Insulin Analogue, Novo-Rapid for Rapid-acting Insulin Analogue and Novo Mix 30 for Dual-Release Insulin Analogue
Haemostasis Management: Novo Seven – Recombinant Factor VIIa Growth Hormones: NordiFlex and Norditropin – the First pre-filled multi-dose hGH Pen
|
|
|
|
|
|
|
AstraZeneka
, Metsubishi Pharma
, Schereeng
, Abott Laboratories
, Senkyo Co
, Chiren Corporation
, Schereeng_Plough
, Johnsun and Johnsun
, Sanophi Aventis
, Ganentech
|
|
|
|
|
| Latest News About novo nordisk |
|
|
Danish shares close somewhat more highly; Danisco... - Color
Color - On the 19th Jun, 2007
COPENHAGEN (Thomson financially) - Novo Nordiskand USA colleague, ZymoGenetics, said used for received that it expects, up to 198 mln, plus monarchy when it registered a....More |
|
|
|
|
LONDON: Shares in Novo Nordisk, fell the worldand that insulin manufacturer leads, 21 percent on Wednesday morning after it cut its salary prediction. ....More |
|
|
|
|
COPENHAGEN (AFX) - share prices were under in midmorning trade, led through down Novo Nordisk, that follows classifies a broker more low, dealers said. ....More |
|
|
|
|
In its year report for 1998, Novo Nordisk announced first its intention to demerge. andquot; it is our goal that public health, enzyme business and our USA discovery....More |
|
|
|
|
Belo horizons - measure should be published today. The tax guilt release of Investitionsgüterern, the change of treatment for financial uses taxes and that....More |
|
|
|
|
Novo Nordisk, the worldand the largest manufacturer of diabetes treatments, ... Under the decision, Novo Nordisk and Genentech, against license certain Patente. becomes...More |
|
|
|
Danish shares close under, led through AP Moeller,... - Color
Color - On the 27th Okt, 2006
COPENHAGEN (AFX) - Novo Nordisk WHEN its control retained for the entire year 2006 after setting up of an operating profit of 7,011 bln dkr for the first nine months....More |
|
|
|
Midmorning higher Danish shares, has by TDC, Novo led... - Color
Color - On the 6th Okt, 2006
A Phasenii study is first to be initiated during the first quarter of 2007 for the use of the insulin Analogon liraglutide when an Antifettleibigkeit expects....More |
|
|
|
|
In Q1 2000, Novo Nordisk has united revenue of. erreicht. On 24 May 2000 Novo Nordisk announced that its NovoPen was 3 demoes....More |
|
|
|
|
Oct. 24--CLAYTON, NC -- construction of Novo Nordiskand $12 million arrangements expansion wasnandt has, but that didnandt stop contractor of celebrations concludes it,....More |
|
|
|
|
|
|
|
